Corporate Banner
Satellite Banner
Genomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Massive Genomics Project Answers Questions, Poses New Ones in Health, Genetics and Aging

Published: Thursday, November 22, 2012
Last Updated: Thursday, November 22, 2012
Bookmark and Share
Initial findings focus on telomere trends with ethnicity, socioeconomic status, lifestyle.

People with the shortest telomeres really do have a date with the Grim Reaper, according to new data coming out of the largest and most diverse genomics, health and longevity project in the nation.

Among the initial results from the Grand Opportunity Project on genetics, health, aging and the environment – a joint project between Kaiser Permanente and UCSF – is the finding that the 10 percent of people with the shortest telomere lengths had more than a 20 percent higher risk of dying during the ensuing three years than any other group.

But whether these shortened DNA nibs at the end of our chromosomes are harbingers of death or actually contribute to our downfall remains in question.

The new findings, and the increasing questions they pose, are some of the first results to emerge from the Kaiser Permanente-UCSF project that was launched in 2009 as the scientific equivalent of the large-scale infrastructure projects of the 1930s, such as the Golden Gate Bridge and the Hoover Dam.

Joining Forces for Massive Genetic Analysis

Supported with $25 million through the American Recovery & Reinvestment Act (ARRA), the project set out to combine the strong epidemiological research and comprehensive, consistent health records at Kaiser Permanente with UCSF’s strengths in genetics and telomere research, to create a national resource that would transform health science into the foreseeable future.

The overall project links a genetic analysis of 110,266 saliva samples collected at Kaiser Permanente of Northern California over the past five years to decades of Kaiser Permanente health records, as well as UCSF measurements of longevity markers and state environmental exposures. That health data includes thousands of pharmacy records and years of cholesterol and lipid tests, as well as mammograms, EKGs and MRI scans, all performed in the same laboratories with consistent techniques.

That is an invaluable resource, the researchers said, and already is starting to show results.

“We discovered 103 different genes underlying HDL and LDL cholesterol and triglyceride levels, with p values (statistical significance) that have never been seen before, and there’s more to come,” said Neil Risch, PhD, director of the UCSF Institute for Human Genetics, who is jointly leading the overall project with Cathy Schaefer, PhD, in the Kaiser Permanente Division of Research.

“What underlies these traits and diseases are many, many genes,” said Risch, a statistical geneticist who already has uncovered numerous genetic SNPS (single nucleotide polymorphisms) through this project that have never before been detected. “To see them all, you need very large samples. That’s what we have in this project.”

Its first results are both substantiating and refuting findings from smaller projects, while posing new questions for scientists to tackle in the years to come.

“We’re at the beginning of some really interesting analyses of telomere length,” said Schaefer, an epidemiologist who led the analyses of the telomere data, after the telomeres were measured in the UCSF laboratory of Nobel laureate Elizabeth Blackburn, PhD.

“We know that telomere length declines with age and several studies have shown that telomere length is related to a number of diseases,” Schaefer said. “The question is whether the length is simply a marker of cumulative experiences, or whether it plays a direct role in health.”

Some Surprising Findings on Telomeres

The initial findings, which stem from a one-year extension to begin analyses using the remainder of the team’s ARRA funding, were presented as talks and posters during the American Society of Human Genetics conference in San Francisco on Nov. 7-8.

Among the findings were a number of genes connected to diabetes, cancer and autoimmune diseases, among other health conditions.

There also was clear evidence that telomeres are longer in African-Americans and in people with higher educational status, while they are shorter for people in low socioeconomic communities. Telomeres also rise sharply in men who are over 75 years old and in women over 80, which the researchers said probably means that these individuals – through genetics or long-term lifestyle – were programmed on a cellular basis to outlast their peers.

Smoking and alcohol consumption also were directly linked to shorter telomeres, with a direct correlation between the number of packs of cigarettes smoked during a lifetime and shorter DNA nibs on an individual’s chromosomes, which the researchers said validated the link between what we know about overall health conditions and our cellular health. But they found no link between exercise and telomere length, which has previously been reported.

The great surprise so far, Schaefer said, was in participants with the highest Body Mass Index, who consistently showed longer telomeres. That’s despite extensive data showing that these individuals have more health problems and worse health prognoses overall.

The UCSF Institute for Human Genetics, through its Genomics Core Facility, also derived genetic information at 700,000 or more locations in the genome for each individual.  The resulting combination of health and genetic data, which includes over 70 billion genotypes and took two years to collect and quantify, is currently available as a resource through the Kaiser Permanente-UCSF team for external researchers studying the genetic or environmental basis of disease.

Later this fall, much of the data also will be incorporated into a national database known as dbGAP, run by the National Institutes of Health, which will be available to researchers worldwide.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,200+ scientific posters on ePosters
  • More than 4,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Transcription Factor Isoforms Implicated in Colon Diseases
UC Riverside study explains how distribution of two forms of a transcription factor in the colon influence risk of disease.
Thursday, May 19, 2016
Fructose Alters Hundreds of Brain Genes
UCLA scientists report that diet rich in omega-3 fatty acids can reverse the damage.
Tuesday, April 26, 2016
Study Yields the Key to Effective Personalized Medicine
A team of UCLA bioengineers and surgeons has taken a major step toward making personalized medicine a reality.
Monday, April 11, 2016
Crowdfunding the Fight Against Cancer
From budding social causes to groundbreaking businesses to the next big band, crowdfunding has helped connect countless worthy projects with like-minded people willing to support their efforts, even in small ways. But could crowdfunding help fight cancer?
Monday, February 08, 2016
Science Magazine Names CRISPR ‘Breakthrough of the Year’
In its year-end issue, the journal Science chose the CRISPR genome-editing technology invented at UC Berkeley 2015’s Breakthrough of the Year.
Monday, December 21, 2015
CRISPR-Cas9 Helps Uncover Genetics of Exotic Organisms
A new study illustrates the ease with which CRISPR-Cas9 can knock out genes in exotic animals to learn how those genes control growth and development.
Friday, December 11, 2015
New Method for Screening Cancer Cells
Parallel microfiltration could lead to better treatments for a number of diseases, UCLA-led study says.
Thursday, December 03, 2015
RNA-Based Drugs Give More Control Over Gene Editing
CRISPR/Cas9 gene editing technique can be transiently activated and inactivated using RNA-based drugs, giving researchers more precise control in correcting and inactivating genes.
Monday, November 23, 2015
Clearest Ever Images of Enzyme that Plays Key Roles in Aging, Cancer
UCLA-led research on telomerase could lead to new strategies for treating disease
Monday, October 19, 2015
Crop Cure
Scientists in new center to use medical research techniques to help food crops withstand drought and climate change.
Friday, October 16, 2015
Rare Childhood Leukemia Reveals Surprising Genetic Secrets
A coalition of leukemia researchers led by scientists from UC San Francisco has discovered surprising genetic diversity in juvenile myelomonocytic leukemia (JMML), a rare but aggressive childhood blood cancer.
Thursday, October 15, 2015
Double Enzyme Hit May Explain Common Cancer Drug Side Effect
Mouse study suggests genomic screening before treatment may help prevent anemia.
Wednesday, October 14, 2015
New Autism Genes Are Revealed in Largest-Ever Study
Work draws more detailed picture of genetic risk, sheds light on sex differences in diagnosis.
Wednesday, September 30, 2015
Scientists Create CRISPR/Cas9 Knock-In Mutations in Human T Cells
In a project spearheaded by investigators at UC San Francisco, scientists have devised a new strategy to precisely modify human T cells using the genome-editing system known as CRISPR/Cas9.
Tuesday, July 28, 2015
Simple Technology Makes CRISPR Gene Editing Cheaper
University of California, Berkeley, researchers have discovered a much cheaper and easier way to target a hot new gene editing tool, CRISPR-Cas9, to cut or label DNA.
Friday, July 24, 2015
Scientific News
Liquid Biopsies: Miracle Diagnostic or Next New Fad?
Thanks to the development of highly specific gene-amplification and sequencing technologies liquid biopsies access more biomarkers relevant to more cancers than ever before.
Discovered Through ‘Big Data’ Analysis
Researchers at the SBP have identified over 100 new genetic regions that affect the immune response to cancer.
New Therapeutic Targets For Small Cell Lung Cancer Identified
Researchers at UTSW Medical Center have identified a protein termed ASCL1 that is essential to the development of small cell lung cancer and that, when deleted in the lungs of mice, prevents the cancer from forming.
Deciphering Inactive X Chromosomes
Untangling the Barr body of inactive X chromosomes valuable for understanding chromosome structure and gene expression.
Micro Disease-Detecting Senor Created
Researchers at McMaster University have created a microscopic disease-detecting sensor that can turn on to detect trace amounts of substances.
Liquid Biopsies Treating Ovarian Cancer
Researchers have discovered a promising monitor and treat recurrence of ovarian cancer. Detecting cancer long before tumours reappear.
Uncovering a New Principle in Chemotherapy Resistance in Breast Cancer
The NIH study has revealed an entirely unexpected process for acquiring drug resistance that bypasses the need to re-establish DNA damage repair in breast cancers that have mutant BRCA1 or BRCA2 genes.
Understanding Treatment Resistant Melanoma
Researchers have determined how advanced melanoma becomes resistant; a development toward developing treatments.
Investigating ‘Black Box’ of Human Genetics
Investigations into inactive X chromosomes have shown unusual DNA repeat elements are essential for maintaining 3D structure.
Liquid Biopsies: DNA Size Matters
Study finds circulating tumour DNA can be distinguished from healthy DNA through fragment size identification.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,200+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!